Two mental health giants combine forces to threaten the crowded mental health app market:: Headspace and Ginger are merging in a $3B deal—we unpack the strategic decisions each made ahead of this megamerger and what smaller mental health players can learn from it.
The mental health app market is becoming extremely saturated: K Health is the latest provider to double down on mental health apps with its Trusst snap up—we unpack how mental health apps can sustain success among the sea of competitors.
What’s next for digital health? Experian Health’s latest survey unveiled patient and provider attitudes toward digital health and how they changed from 2020 to 2021—we unpack how the survey’s highlighted demand for online-scheduling tools reveals future opportunities for digital health vendors.
Virtual reality for healthcare is heating up: NeuPath and Cynergi are teaming up to launch a VR solution for chronic pain management—we unpack the market landscape of VR in healthcare and why this could pique insurers' interest.
The demise of Apple’s HealthHabit app is a sign it may need to focus its health endeavors on what it knows best: devices. The tech giant’s health app has been scrutinized following untrustworthy results from a hypertension pilot—we outline the bigger picture of the company’s recent struggles in healthcare.
Google dismantles Google Health as Big Tech struggles to get their health endeavors off the ground: We unpack why Big Tech firms are having trouble operating as health tech firms.
The American Hospital Association wrote a letter to the federal goverment speaking favor of hospital mergers—we explore the tug of war between hospitals and consumer interests around hospital M&As.
Some hospitals can’t afford to make digital health investments right now: Not-for-profit health system Cone Health poured $12M into a digital diabetes management solution, and then abandoned it—highlighting how digital health investments aren’t feasible for all hospitals and health systems despite their ability to improve patient health.
Verily’s 1st major acquisition signals it’s springboarding its digital clinical research efforts: We unpack how Verily’s SignalPath snap up could complement Google’s other healthcare ventures.